Приказ основних података о документу

dc.creatorKrstevska, Aleksandra
dc.creatorNedelkov, Ivana
dc.creatorPetrović, Maša
dc.creatorIbrić, Svetlana
dc.creatorMirković, Dušica
dc.creatorCvijić, Sandra
dc.date.accessioned2023-10-03T12:23:02Z
dc.date.available2023-10-03T12:23:02Z
dc.date.issued2023
dc.identifier.issn1857 - 8969
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/5053
dc.description.abstractPrecipitation of a drug substance in the small intestine is a phenomenon relevant to weak bases due to their pH- dependent solubility. Because of the low solubility at higher pH, upon entry in the small intestine, a weak base may get into a supersaturated state, which is thermodynamically unstable and tends to precipitate (Makitalo, 2019). Consequently, precipitation in the gastrointestinal (GI) tract may significantly limit oral bioavailability (BA) of poorly soluble, weak bases. Several in vitro and in silico tools are available for assessing the precipitation kinetics of weakly basic compounds (Kou et al., 2018). The dynamic nature of physiologically based in silico models and their ability to treat drug dissolution and precipitation as variables affecting concomitant drug bioperformance make in silico models a powerful tool to assess the impact of these variables on drug absorption. The aim of this work was to in silico evaluate the influence of possible variations in the values of GI physiological parameters on the potential precipitation and absorption of a weakly basic, poorly soluble and highly permeable compound. ...sr
dc.language.isoensr
dc.publisherMacedonian Pharmaceutical Associationsr
dc.publisherSs. Cyril and Methodius University in Skopje, Faculty of Pharmacysr
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//sr
dc.rightsopenAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceMacedonian Pharmaceutical Bulletinsr
dc.titleIn silico assessment of intestinal precipitation: Case study of a poorly soluble, weakly basic compoundsr
dc.typeconferenceObjectsr
dc.rights.licenseBYsr
dc.citation.volume69
dc.citation.issueSuppl 1
dc.citation.spage127
dc.citation.epage128
dc.description.other14th Central European Symposium on Pharmaceutical Technology, 28th - 30th September, Ohrid, N. Macedonia, 2023sr
dc.identifier.doi10.33320/maced.pharm.bull.2023.69.03.062
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/13944/In_silico_assessmen_pub_2023.pdf
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу